Reference 2016-244

REF:            2016-244

Subject:        Intra-vitreal injections/implants

    

 

Request:

Within your trust how many intra-vitreal injections/implants have been used in the latest 4 months, if possible between January to April 2016

If your trust is able to identify injections/implants by eye conditions please split by the drug used [ranibizumab, bevacizumab, aflibercept, Fluocinolone and Dexamethasone].

 

 

Response:

 

Below are the number of intra-vitreal injections/implants that have been used between January and April 2016.

 

  Lucentis (ranibizumab) Injections Avastin (bevacizumab) Injections Eylea (aflibercept) Injections Illuvien (Fluocinolone) Impants Ozudex (Dexamethasone) Implants
Total  1130  0  586  1 21 

 

Visitor restrictions

To protect you and our staff during the current outbreak of Covid-19 we’ve put in place significant restrictions on hospital visitors.

Full details of these can be found on our website.

We would like to thank you for your understanding and helping us stop the spread of Covid-19.

Read More

Stay Home. Protect the NHS. Save Lives.

Close